Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

GSK expands cost cutting drive

February 9, 2009
Sales and Marketing GSK, restructure

GlaxoSmithKline has expanded its restructuring plans and will make widespread job cuts in a bid to cut costs throughout its …

News

GSK hopeful of NICE approval for Tyverb

January 26, 2009
Sales and Marketing Cancer, GSK, breast cancer

NICE could be poised to reverse its rejection of GSK's breast cancer treatment Tyverb, the pharma company has said.NICE rejected …

News

GSK opens US hub for vaccine manufacturing

January 14, 2009
Manufacturing and Production GSK

GlaxoSmithKline has officially unveiled a $300 million manufacturing plant in Pennsylvania that will serve as the cornerstone of its US …

News

GSK halts political funding

January 5, 2009
Sales and Marketing GSK, ethics

GlaxoSmithKline will no longer make corporate political donations in a bid to make its dealings with governments more transparent and …

News

GSK signs flu partnership

November 26, 2008
Sales and Marketing China, GSK, vaccines

News

GSK delays US filing of Solzira

November 14, 2008
Sales and Marketing GSK, restless legs

GlaxoSmithKline has withdrawn the US application for its restless legs syndrome treatment Solzira. The company, along with co-developer XenoPort, is …

News

GSK to close Dartford manufacturing site by 2013

November 14, 2008
Manufacturing and Production GSK

GlaxoSmithKline has announced plans to close its manufacturing site in Dartford in the UK, with operations being phased out over …

News

GSK to acquire Hepatitis C specialists Genelabs

October 30, 2008
Sales and Marketing GSK, Genelabs, MA

GlaxoSmithKline is to pay $57 million (£35 million) for Genelabs, California-based specialists in infectious diseases, including hepatitis C. The companies …

News

GSK takes Egyptian lead

October 16, 2008
Sales and Marketing Egypt, GSK, em

GlaxoSmithKline has extended its reach into emerging markets by acquiring Bristol-Myers Squibb’s Egyptian mature products business for £125 millionThe move …

News

GSK’s pricing deal for Tyverb fails to sway NICE

October 15, 2008
Sales and Marketing GSK, NICE, breast cancer

NICE has spurned GSK's risk-sharing proposal for its breast cancer treatment Tyverb, saying the drug is still too expensive to …

News

GSK plans research job losses in UK

October 3, 2008
Research and Development GSK, restructure

GlaxoSmithKline is set to cut about 850 jobs in early-stage research and development at sites across the world, including the …

News

GSK seeks risk-sharing deal for Tyverb

September 17, 2008
Sales and Marketing Cancer, GSK, NICE, par

GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …

News
Paolo

GSK unveils new cancer unit

September 17, 2008
Research and Development Cancer, GSK

 GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …

News

Viehbacher leaves GSK for Sanofi

September 10, 2008
Sales and Marketing GSK, Sanofi

Chris Viehbacher is set to leave GlaxoSmithKline for a lead role at Sanofi-Aventis after last year losing out to Andrew …

News

Witty outlines GSK’s new strategic priorities

July 24, 2008
Sales and Marketing GSK

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025